Abivax ABVX Cash Flow Statement (2022-2026)

NASDAQ ABVX
$96.85 +5.79 (+6.36%)
At close: Sep 28, 2026 · 4:00 PM EDT
Reported Financials

Abivax Quarterly Cash Flow Statement

Periods 12 quarters
Latest Jun 2026

Abivax reported cash from operations of -$0.06B and free cash flow of -$0.06B for the quarter ended Jun 2026, down 60.1% year over year. This cash flow statement covers 12 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -61.93-159.02-0.05B-0.04B-0.06B-188.19B-0.06B-0.05B-0.18B-390.94B-0.06B-0.14B
Share-based Compensation 0.01B0.01B0.00B21.59B0.00B0.01B0.01B41.18B0.03B0.02B
Deferred Taxes -0.00B-0.00B0.01B-0.00B0.03B-0.03B-0.01B
Cash from Discontinued Operations -0.01B-166.04B-0.04B-0.05B-0.08B-191.63B-0.05B-0.06B
Non-cash Items -0.04B-0.04B-0.04B-0.05B
Change in Working Capital 0.00B-0.02B0.01B1.52B0.01B0.01B-0.00B4.23B-0.01B0.00B
Change in Receivables -0.00B0.01B-0.00B4.90B-0.00B0.01B-0.01B8.20B-0.00B-0.00B
Change in Account Payables 0.01B-0.02B0.02B-3.68B0.01B0.00B-0.03B-7.21B-0.01B0.01B
Change in Accured Expenses 1.51B0.00B-0.00B0.07B72.48B
Other Working Capital Changes -0.00B0.00B-0.00B-1.59B-0.00B0.00B0.01B2.45B0.01B-0.01B
Cash from Operations -0.04B-0.05B-0.04B-164.51B-0.04B-0.04B-0.08B-187.40B-0.06B-0.06B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization 0.00B0.00B0.00B1.17B0.00B0.00B0.00B1.25B0.00B0.00B
Investing Activities
Capital Expenditures 0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B
Sales of Property, Plant and Equipment -0.00B-0.00B-0.00B-0.68B-0.00B-0.00B0.00B-0.17B-0.00B-0.00B
Change in Intangibles -0.00B
Cash from Investing Activities 0.00B0.01B0.00B16.83B0.00B0.00B0.00B-9.54B0.00B0.00B
Financing Activities
Other financing activities 0.00B0.00B0.00B0.26B0.00B-0.00B0.00B0.35B
Debt Issuance and Repayment
Long-Term Debt Issuances 0.03B0.03B-0.00B51.18B
Long-Term Debt Repayments -0.00B-0.00B-0.00B-9.34B-0.00B-0.01B-0.01B-62.75B
Change in Capital Stock
Net Equity Issued and Repurchased 0.00B6.77B0.00B0.00B
Misc.
Cash from Financing Activities 0.02B0.02B-0.01B30.11B-0.01B-0.01B0.71B636.41B0.00B-0.05B
Exchange Rate Effect 0.00B0.00B-0.00B2.55B-0.00B-0.00B-0.01B-11.92B0.01B-0.00B
Change in Cash -0.01B-0.02B-0.05B-115.03B-0.04B-0.05B0.62B433.05B-0.05B-0.10B
Beginning Cash Balance 0.27B0.15B
Free Cash Flow -0.04B-0.05B-0.04B-164.51B-0.04B-0.04B-0.08B-187.40B-0.06B-0.06B
Net Cash Flow -0.01B-0.02B-0.04B-117.58B-0.04B-0.05B0.63B439.46B-0.06B-0.11B

Abivax Cash Flow Statement API

Pull Abivax's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ABVX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY